Brind.
  1. Trump's pledge to unleash oil and gas is reported to benefit 15 US stocks, including VSE.
  2. Trump's pledge to unleash oil and gas is reported to benefit stocks, involving Nexters.
  3. Trump's pledge to unleash oil and gas is reported to benefit 15 US stocks, including VSE.
  4. Trump's pledge to unleash oil and gas is reported to benefit stocks, involving Nexters.

Trump's pledge to unleash oil and gas benefits stocks, involving Willis Towers Watson.

8 reports, 1 independent Updated Aug 26
Gone quiet
Reports
8
Developments
7
Repetition
12%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Trump's pledge to unleash oil and gas benefits stocks, involving Willis Towers Watson.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Trump's pledge to unleash oil and gas benefits stocks, impacting Alnylam Pharmaceuticals.1 source
  2. Willis Towers Watson is mentioned in relation to Trump's pledge to unleash oil and gas.1 source
  3. Trump's pledge to unleash oil and gas is reported to benefit stocks, involving Texas Roadhouse.1 source
  4. Trump links his oil/gas pledge to benefits for NewAmsterdam Pharma.1 source
  5. Trump linked his oil and gas pledge to benefits for US stocks, including Recursion Pharmaceuticals.1 source
  6. ANI Pharmaceuticals is among the 15 US stocks expected to benefit from Trump's pledge.1 source
  7. Texas Instruments is cited as a stock benefiting from Trump's oil and gas pledge.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • Simply Wall St.Calculating The Fair Value Of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Alnylam Pharmaceuticals' estimated fair value is US$531 based on 2 Stage Free Cash Flow to Equity Current share price of US$4
  • Simply Wall St.Willis Towers Watson (NASDAQ:WTW) shareholders have earned a 13% CAGR over the last five years The main point of investing for the long term is to make money. But more than that, you probably want to
  • Simply Wall St.3 Stocks That May Be Trading Below Their Estimated Value As the U.S. stock market continues its rally, with major indices like the S&P 500 and Nasdaq reaching new highs, investors are increasingly on
  • Simply Wall St.The Texas Roadhouse, Inc. (NASDAQ:TXRH) Second-Quarter Results Are Out And Analysts Have Published New Forecasts Explore Texas Roadhouse's Fair Values from the Community and select yours Shareholders
  • Simply Wall St.Analysts Are Upgrading NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) After Its Latest Results Explore NewAmsterdam Pharma's Fair Values from the Community and select yours NewAmsterdam Pharma Compan
  • Simply Wall St.Broker Revenue Forecasts For Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Are Surging Higher Explore Recursion Pharmaceuticals's Fair Values from the Community and select yours Recursion Pharmaceuti
  • Simply Wall St.ANI Pharmaceuticals (NASDAQ:ANIP) pulls back 4.3% this week, but still delivers shareholders strong 16% CAGR over 5 years When you buy shares in a company, it's worth keeping in mind the possibility
  • Simply Wall St.Are Texas Instruments Incorporated (NASDAQ:TXN) Investors Paying Above The Intrinsic Value? Texas Instruments' estimated fair value is US$152 based on 2 Stage Free Cash Flow to Equity Texas Instrumen